5 employees
AROMICS is committed to the discovery and development of novel drugs and diagnostic methods to target relevant human health diseases.
2005
$1.8M
from 2 investors over 2 rounds
AROMICS raised $1.8M on February 18, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)
AROMICS raised $321K on April 1, 2017
Investors: Capital Cell